Article Text

Download PDFPDF
What is the cost of pelvic inflammatory disease and how much could be prevented by screening for Chlamydia trachomatis? Cost analysis of the Prevention Of Pelvic Infection (POPI) trial
  1. Adamma Aghaizu1,
  2. Elisabeth J Adams2,
  3. Katy Turner3,
  4. Sally Kerry1,
  5. Phillip Hay4,
  6. Ian Simms5,
  7. Pippa Oakeshott1
  1. 1Population Health Sciences and Education, St George's University of London, London, UK
  2. 2Health Economics Consultant, London, UK
  3. 3Department of Community and Social Medicine, University of Bristol, Bristol, UK
  4. 4Department of Genitourinary Medicine, St George's Hospital, London, UK
  5. 5HIV and STI Department, Health Protection Agency, Centre for Infections, London, UK
  1. Correspondence to Adamma Aghaizu, St George's, University of London, London SW17 0RE, UK; aaghaizu{at}sgul.ac.uk

Footnotes

  • Funding This study was supported by the BUPA Foundation (grant no 684/GB14B).

  • Competing interests None declared.

  • Ethics approval This study was approved by Wandsworth research ethics committee (reference 03.0012).

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Funding This study was supported by the BUPA Foundation (grant no 684/GB14B).

  • Competing interests None declared.

  • Ethics approval This study was approved by Wandsworth research ethics committee (reference 03.0012).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.